Silodosin glucuronide is a Phase II metabolite of the ฮฑ1-adrenergic antagonist Silodosin, formed via glucuronidation of the parent compound's tertiary amine. The structure features a dibenzazepine scaffold conjugated to a ฮฒ-D-glucuronic acid moiety through an N-glycosidic linkage, introducing a carboxylic ester and multiple hydroxyl groups. This conjugation enhances water solubility while retaining the core pharmacophore. The compound serves as an HPLC reference standard for quantifying Silodosin-related impurities in pharmaceutical formulations.
On RequestC[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)NCCOC4=CC=CC=C4OCC(F)(F)F
InChI=1S/C31H40F3N3O10/c1-17(36-8-12-44-21-5-2-3-6-22(21)46-16-31(32,33)34)13-18-14-19-7-10-37(23(19)20(15-18)28(35)41)9-4-11-45-30-26(40)24(38)25(39)27(47-30)29(42)43/h2-3,5-6,14-15,17,24-27,30,36,38-40H,4,7-13,16H2,1H3,(H2,35,41)(H,42,43)/t17-,24+,25+,26-,27+,30-/m1/s1
ZSZSAUNNNUTBDH-UPUDQGLBSA-N